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Abstract
Background: Clinical prediction models (CPMs) are increasingly deployed to support healthcare decisions but they
are derived inconsistently, in part due to limited data. An emerging alternative is to aggregate existing CPMs
developed for similar settings and outcomes. This simulation study aimed to investigate the impact of between-
population-heterogeneity and sample size on aggregating existing CPMs in a defined population, compared with
developing a model de novo.
Methods: Simulations were designed to mimic a scenario in which multiple CPMs for a binary outcome had been
derived in distinct, heterogeneous populations, with potentially different predictors available in each. We then
generated a new ‘local’ population and compared the performance of CPMs developed for this population by
aggregation, using stacked regression, principal component analysis or partial least squares, with redevelopment
from scratch using backwards selection and penalised regression.
Results: While redevelopment approaches resulted in models that were miscalibrated for local datasets of less than
500 observations, model aggregation methods were well calibrated across all simulation scenarios. When the size of
local data was less than 1000 observations and between-population-heterogeneity was small, aggregating existing
CPMs gave better discrimination and had the lowest mean square error in the predicted risks compared with
deriving a new model. Conversely, given greater than 1000 observations and significant between-population-
heterogeneity, then redevelopment outperformed the aggregation approaches. In all other scenarios, both
aggregation and de novo derivation resulted in similar predictive performance.
Conclusion: This study demonstrates a pragmatic approach to contextualising CPMs to defined populations. When
aiming to develop models in defined populations, modellers should consider existing CPMs, with aggregation
approaches being a suitable modelling strategy particularly with sparse data on the local population.
Keywords: Clinical prediction models, Model aggregation, Validation, Computer simulation, Contextual
heterogeneity
Background
Clinical prediction models (CPMs), which compute the
risk of an outcome for a given set of patient characteris-
tics, are fundamental to clinical decision support sys-
tems. For instance, practical uses of CPMs include
facilitating discussions about the risks associated with a
proposed treatment strategy, assisting audit analyses and
benchmarking post-procedural outcomes. Consequently,
there is growing interest in developing CPMs to support
local healthcare decisions [1, 2]. Although there might
be existing models derived for similar outcomes and
populations, it is vital they are appropriately updated,
validated and transferred between different contexts of
use. Baseline risk and predictor effects may differ across
populations, which can cause model performance to de-
crease when transferring an existing CPM to the local
population [3–6]. This between-population-heterogeneity
frequently leads to researchers rejecting existing models
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and developing new ones [5, 7–10]. However, this frame-
work is undesirable because the dataset used to derive the
new CPM is often smaller than previous derivation
datasets and can lead to multiple models for the same
outcome. For instance, over 60 previously published
models predict breast cancer [11], which is perplexing
and unhelpful to end-users.
As a motivating example, consider a user wishing to
predict short-term mortality post cardiac-surgery. There
are several existing CPMs available, including the Logistic
EuroSCORE (LES), the EuroSCORE II (ESII), the STS
score and the German Aortic Valve Model (German AV)
[12–16]. These models share some common predictors,
for example gender, arterial disease outside the heart and
recent heart attack, but some predictors appear only in a
subset of the CPMs. For instance, diabetes is only incorpo-
rated into the ESII and STS models, while atrial fibrillation
is only in the STS and German AV models. Moreover, def-
initions and coding of some predictors could differ: exam-
ples include left ventricular ejection fraction and age.
While differences in variable definitions between existing
CPMs add complexity, the prior information encapsulated
by each model can be exploited. A generalizable existing
CPM could serve as an informative prior for a new popula-
tion; for example, by transferring information regarding
likely covariate-outcome relations, as in stacked regression
[9, 17]. However, there has been limited investigation
into the impact of sample size and between-population-
heterogeneity on the performance of model aggregation
versus deriving a new CPM.
This simulation study considers a situation in which
there is a new (local) population, with associated data,
and interest lies in developing a CPM for it. The model-
ler must make a choice between utilising existing CPMs
that have been developed in different populations, devel-
oping a new model and disregarding existing ones, or
some mixture of the two [18]. We hypothesised that the
modelling strategy that optimised performance would
depend on: 1) the degree of variation in risk across mul-
tiple populations (between-population-heterogeneity);
and 2) the quantity of data available in the local popula-
tion, relative to the size of previous derivation datasets.
Methods
Throughout this study, all CPMs will be assumed to be
logistic regression models, although the techniques apply
to other types of prediction model, such as those for
time-to-event outcomes. Stacked regression (SR) [9, 17],
principal component analysis (PCA) [19, 20] and partial
least squares (PLS) are three possible methods that sim-
ultaneously aggregate and calibrate existing models to a
new population. We describe SR and PCA here, with PLS
described in Additional file 1. This study compares the
three aforementioned aggregate approaches with deriving
a new model; possible techniques of redevelopment are
also outlined in this section.
Model aggregation: stacked regression
Consider a collection of M existing logistic regression
CPMs, which all aim to predict the same binary outcome
but were derived in different populations, j = 1,…,M.
For a set of observations i = 1,…, nj from population j,
let Xj denote the nj × P matrix of predictors that are po-
tentially associated with the outcome, Yj. Here, P repre-
sents the number of predictors available across all
populations; a predictor that is not present in a given
CPM simply has coefficient zero. Then, for i = 1,…, nj,
the linear predictor (LP) from the jth existing CPM,
LPi,j, is given by
LPi;j ¼ β0;j þ
XP
p¼1
βp;jxi;p
with intercept β0,j and coefficients β1,j, …, βP,j, at least
one of which is non-zero.
Suppose we then have a new local population, j =M + 1.
Stacked regression aims to weight the M linear predictors
(calculated for each observation in the new local popula-
tion) to maximise the logistic regression likelihood. Specif-
ically, SR assumes that for i = 1,…, nM + 1, Yi,M + 1 ∼
Bernoulli(πi,M + 1) where πi,M + 1 = P(Yi,M + 1 = 1) with
log
πi;Mþ1
1−πi;Mþ1
 
¼ γ^ 0 þ
XM
j¼1
γ^ jLPi;j
under the constraint that γ^ 1;…; γ^M≥0 to account for
collinearity between the existing CPMs. Here, LPi,j de-
notes the linear predictor from the jth existing CPM
calculated for observation i ∈ [1, nM + 1] in the new local
population. Thus, we have
log
πi;Mþ1
1−πi;Mþ1
 
¼ γ^ 0 þ
XM
j¼1
γ^ jβ0;j þ
XP
p¼1
XM
j¼1
γ^ jβp;jxi;p;
which can be used to calculate subsequent risk predictions
for a new observation. The hat accent above parameters
indicates those that are estimated from the local popula-
tion data. Specifically, SR estimates γ^ j but not βp,j, which
are taken as fixed values from the published existing CPM.
Model aggregation: Principal Components Analysis (PCA)
regression
Let LP denote the nM + 1 ×M matrix, with (i, j)
th element
being the linear predictor for the jth existing CPM calcu-
lated for observations i = 1,…, nM + 1 in the local popula-
tion. The singular value decomposition of LP gives an
M ×M rotation matrix, ν. Multiplying LP by ν, gives the
nM + 1 ×M matrix of principal components, Z. PCA
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regression again assumes that Yi,M + 1 ∼ Bernoulli(πi,M + 1)
for i = 1,…, nM + 1 with
log
πi;Mþ1
1−πi;Mþ1
 
¼ θ^0 þ
XM
j¼1
θ^ jZi;j:
Unlike in SR, no restrictions are placed on the parameters
θ^ j since, by definition, the principal components, Z, are
uncorrelated. One can obtain predictions for a future
observation by converting the above aggregate model
onto the scale of the original risk factors,
log
πi;Mþ1
1−πi;Mþ1
 
¼ θ^0 þ
XM
j¼1
θ^ j LPi;1v1;j þ…þ LPi;MvM;j
 
¼ θ^0 þ
XM
j¼1
XM
r¼1
θ^ jvr;jLPi;r:
Model redevelopment
Let XM + 1 denote the nM + 1 × P matrix of predictors in
the local population with associated binary outcomes
YM + 1. Then the redevelopment approaches aim to de-
rive a new CPM of the form
log
πi;Mþ1
1−πi;Mþ1
 
¼ β^0;Mþ1 þ
XP
p¼1
β^p;Mþ1xi;p
for i = 1,…, nM + 1, model intercept, β^0;Mþ1, and coefficients,
β^p;Mþ1 , thereby disregarding the existing CPMs. In this
study, two strategies of redevelopment were considered;
namely, backwards selection using Akaike Information Cri-
terion (AIC) and penalised maximum likelihood estimation
(ridge regression). The AIC of a model is defined as 2k − 2
log(L), where k is the number of estimated parameters and
L is the maximum likelihood value. Backwards selection
under AIC proceeds by starting with the full model (i.e. all
available predictors) and iteratively removing predictors
until the model that minimises the AIC is obtained. Con-
versely, ridge regression estimates the coefficients from the
full model by maximising the following penalised log-
likelihood function
l β^Mþ1
 
¼
XnMþ1
i¼1
yi log πi;Mþ1
 þ 1−yið Þ log 1−πi;Mþ1  	
 !
−λ
XP
p¼1
β^p;Mþ1
 2 !
:
Thus, the penalty shrinks the model coefficients to-
wards zero, with λ controlling the degree of penalisation;
cross-validation was used to select λ that minimised the
deviance function.
Simulation design: general overview
Figure 1 visualises the simulation design. The simulation
procedure generated both Normally distributed continu-
ous predictors and Bernoulli distributed binary predic-
tors, each within clusters of serially correlated variables
Fig. 1 Simulation Procedure: A pictorial representation of the simulation procedure for a given value of population heterogeneity, σ, and a given
development sample size, ntrain. This process was then repeated across all combinations of σ and ntrain
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to represent multiple risk factors that measure similar
patient characteristics. Such data were row partitioned
into M = 5 distinct subsets of size nexist = 5000 representing
five “existing populations”, and one subset of size nlocal
representing the “local population”. The M = 5 existing
populations were each used to fit an existing logistic regres-
sion CPMs representing those available from the literature,
with each CPM including a potentially overlapping subset
of risk predictors (see Additional file 1: Table S1 for
details of predictor selection for the existing CPMs).
The single local population was randomly split into a
training and validation set, of sizes ntrain and nvalidate,
respectively (i.e. nlocal = ntrain + nvalidate). The training
set was used for model aggregation using SR, PCA and
PLS in addition to redevelopment using AIC and ridge
regression. Datasets frequently only collect a subset of
the potential risk factors; to recognise this, exactly
those predictors that were included in any of the five
existing CPMs were considered candidates during re-
development. Between simulations ntrain was varied
through (150, 250, 500, 1000, 5000, 10000); the valid-
ation set was reserved only to validate the models with
nvalidate fixed at 5000 observations. Whilst it is unlikely
that local populations would have access to such a large
validation set, this was selected here to give sufficient
event numbers for an accurate assessment of model
performance [21–23]. Additionally, although bootstrap-
ping methods are preferable to assess model performance
in real-world datasets, the split-sample method was
employed here for simplicity and clear illustration of the
methods [24].
Binary responses were simulated in all populations
with probability calculated from a population-specific
generating logistic regression model, which included a
subset of the simulated risk predictors. The coefficients
of each population-specific generating model were sam-
pled from a normal distribution, with a common mean
across populations and variance σ. Here, higher values of
σ induced greater differences in predictor effects across
populations and thus represented increasing between-
population-heterogeneity. For each of the aforementioned
values of ntrain, simulations were run with σ values of (0,
0.125, 0.25, 0.375, 0.5, 0.75, 1).
Across every combination of σ and ntrain, the simula-
tion was repeated over 1000 iterations as a compromise
between estimator accuracy and computational time.
The simulations were implemented using R version 3.2.5
[25]. The following packages were used in the simula-
tion: “pROC” [26] to calculate the AUC of each model,
“plsRglm” [27] to fit the PLS models and the “cv.glmnet”
function within the “glmnet” package for deriving a
new model by cross-validated ridge regression [28].
The authors wrote all other code, which is available in
Additional file 1.
Simulation design: data-generating mechanisms
In practice, modellers could define any one risk factor
through different but potentially related variables and
multiple risk factors within a model could be correlated.
Hence, the simulation procedure generated risk predictors
within clusters of serially correlated variables. Specifically,
P = 50 predictors were generated within 10 clusters, so
that each cluster included K = 5 predictors. Predictors had
serial correlation within each cluster but were independ-
ent between clusters. To represent common real data
structures, the simulation generated clusters of binary and
continuous predictors in an approximately 50/50 split,
with the ‘type’ of each cluster decided at random before
each simulation. For simplicity, clusters did not ‘mix’ bin-
ary and continuous variables. If XN × P denotes the N × P
matrix of predictors (where N is the cumulative sample
size across all populations) and ρ denotes the within-cluster
correlation, then the process to generate the predictors
was adapted from previous studies [29] as follows:
1. If cluster κ includes only continuous predictors then
simulate N realisations of the predictors at the ‘start’
of the cluster as
Xp∼Normal 0; 1ð Þ;
and simulate the remaining K-1 correlated predictors
as
Xp∼ρXp−1 þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1−ρ2ð Þ
p
Ψ;
where Ψ ∼Normal(0, 1).
2. Else, if cluster κ includes only binary predictors, we
generate them as latent Normal. Specifically,
simulate N realisations of the predictors at the ‘start’
of each cluster as
Xp∼Normal 0; 1ð Þ;
and simulate the remaining K-1 correlated predictors as
Xp∼
Xp−1 with prob: ρ
Ψ with prob: 1−ρ

where Ψ ∼Normal(0, 1). Each variable in the cluster
was then dichotomized to give a pre-defined cluster-
specific event rate between 10 and 50%, which are
values frequently reported in observational datasets.
3. Repeat steps 1 to 2 across all κ = 10 clusters.
Sensitivity analyses across a range of within-cluster
correlations, ρ ∈ [0, 0.99] showed that the results were
qualitatively similar; the results given are for ρ = 0.75.
Binary responses for individuals i = 1,…, nj in population
j were sampled from a population-specific generating lo-
gistic regression model with P(Yi,j = 1) = qi,j, where
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log
qi;j
1−qi;j
 !
¼ α0;j þ
XP¼50
p¼1
αp;jxi;p
with intercept α0,j and generating coefficients α1,j,…, α50,j.
If α represents the vector of mean predictor effects across
all populations, then the simulation mechanism in each
population j and generating parameter p = 1,…, 50 was
αp;j∼
N αp; σ2
 
if p≡1 mod K ¼ 5ð Þ
0 otherwise

The p≡1 (mod K = 5) condition implies (without loss
of generality) that in each population, all non-zero gener-
ating coefficients were those at the ‘start’ of each cluster.
Further, such a simulation procedure induced between-
population-heterogeneity by applying random variation to
the mean predictor-effects ( α ), which was controlled
through the value of σ that was introduced above. To
represent coefficients frequently reported in published
models, α was sampled in each simulation as follows:
αp∼
Uniform 0:80; 1:6ð Þ if parameter p is binary
Uniform 0:08; 0:1ð Þ if parameter p is continuous

In addition, baseline risk undoubtedly differs between
populations and, as such, each intercept α0,j was selected
to give an average pre-defined event rate of 20% plus
random variation. All simulations were repeated with an
event rate of 50%, reflecting a 1-to-1 case-control study.
A sensitivity analysis was undertaken where the magni-
tude of α was different across the generating predictors
(see Additional file 1 for details), but the results were
qualitatively similar as those presented here and so are
omitted.
Simulation design: performance measures
For each iteration within a given simulation scenario,
the mean squared error (MSE) between the predicted
risk from each aggregate/new model and the actual risk
from the generating model were calculated across all
samples in the validation set. That is, for model m we
have, MSEm ¼ 1nvalidate
X
i¼1
nvalidate π^ i;m−qi
 2
, where π^ i;m is
the predicted risk from model m for observation i in the
validation set and qi is the generating model risks for
this observation. Similarly, the MSE was calculated be-
tween the estimated coefficients of each aggregate/
new model and the generating coefficients (i.e. MSEm
¼ 1P
X
p¼1
P β^p;m−αp;Mþ1
 2
, where β^p;m is the estimated
pth coefficient from model m and αp,M + 1 is the p
th
generating coefficient in the local population). Add-
itionally, the calibration and discrimination of each
aggregate/new model were calculated in the validation set.
The calibration was quantified with a calibration intercept
and slope, where values of zero and one respectively
represent a well-calibrated model [30]. Discrimination
was evaluated by the area under the ROC curve (AUC).
All performance measures were averaged across iterations
and the empirical standard errors were calculated.
Results
Simulated between-population heterogeneity
To gain a practical understanding of the between-
population-heterogeneity generated by increasing values
of σ, for all simulated parameters the difference between
the largest coefficient and smallest coefficient across
populations was calculated and summarised (Table 1);
such values were compared with corresponding values
from the surgical models. Coefficient differences over
the LES, ESII, STS and German AV represent heterogen-
eity across cardiac surgery risk models each developed
across multiple countries. Coefficient differences over
these models closely matched those generated with σ = 0.25
or σ = 0.375. Conversely, LES and ESII are two models that
were developed on very similar cohorts of patients; here,
the coefficient differences most closely match those gener-
ated by σ = 0.125. Similarly, the average standard deviation
of the coefficients across the LES, ESII, STS and German
AV models was 0.33 (closely matching σ = 0.375), while
that between the LES and ESII was 0.26 (closely matching
σ = 0.25). Together, this suggests that σ values between 0
Table 1 Summary measures of the difference in generating coefficients values across all simulated populations
σ LES, ESII, STS,
German AV
LES, ESII
0 0.125 0.25 0.375 0.5 0.75 1
Lower Quartilea 0 0.29 0.58 0.86 1.16 1.74 2.31 0.37 0.14
Mediana 0 0.31 0.63 0.95 1.27 1.90 2.52 0.57 0.31
Meana 0 0.32 0.63 0.95 1.27 1.90 2.53 0.70 0.37
Upper Quartilea 0 0.34 0.68 1.03 1.38 2.06 2.74 0.85 0.54
SDb 0 0.12 0.24 0.36 0.48 0.71 0.95 0.33 0.26
The values for the LES, ESII, STS and German AV are approximate, since variable definitions vary between CPMs
a: values represent summary measures across all iterations of the average difference between the largest coefficient and smallest coefficient across populations
b: the average standard deviation (SD) of each coefficient across all populations. All values aim to guide the between-population heterogeneity induced through
different σ values
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and 0.375 likely represent the majority of clinical situations,
with σ values greater than 0.5 arguably rare in practice.
Mean square error
For training set samples of 500 or less and when σ ≤ 0.25,
all three aggregation approaches resulted in predicted risks
that had smaller mean square error and lowered the vari-
ance component of the error compared with redevelop-
ment (Additional file 1: Table S2). Similarly, for training
sample sizes less than or equal to 500, SR had estimated
coefficients with consistently smaller mean square error
with lower standard error than the redevelopment ap-
proaches, with the exception of the two highest values
of σ (Additional file 1: Table S3). Conversely, for train-
ing samples of 1000 or more, developing a new model
by ridge regression provided parameter estimates with
at least equivalent MSE to the aggregation methods.
Model calibration
The calibration intercepts for all the aggregate/new
models were not significantly different from zero in the
validation set across all simulations (Fig. 2). Across all
values of σ and for training set sizes smaller than 1000,
the calibration slope of the AIC derived model was sig-
nificantly below one indicating overfitting, while that for
ridge regression was higher than one, indicating slight
over-shrinkage on the parameters (Fig. 3). Conversely,
the three aggregate models had a calibration slope not
significantly different from one in any scenario, with the
exception of PCA in the smallest sample sizes.
Model discrimination
When σ ≤ 0.125 and for training sets of 250 or fewer, the
AUC of SR was significantly higher than that of both re-
development approaches (Fig. 4). Although the 95% confi-
dence intervals overlapped, when σ < 0.25 and the training
set was less than 1000 observations, the AUC of the two
newly derived models (AIC/ridge) were less than that of
the aggregate approaches (Additional file 1: Table S4).
For instance, when σ = 0, the AUC of SR was higher than
that of ridge regression in 988, 968, 821, 498, 56 and 19
out of the 1000 iterations for training set sizes 150, 250,
Fig. 2 Calibration Intercept: Calibration intercept in the validation set for SR, PCA and the two newly derived models across all simulation
situations. The PLS results were nearly identical to SR/PCA and so are omitted for clarity. Note: σ = 1 was removed from the plot for clarity since
the results quantitatively similar to σ = 0.75
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500, 1000, 5000 and 10000, respectively. Hence, given
training set samples of less than 500 and very similar
populations, SR provides consistently higher AUC than
redevelopment by either ridge or backwards selection.
Modelling strategy recommendations
A framework that compared modelling strategies of re-
development and aggregation was developed. For re-
development, ridge regression was always recommended
over AIC since the former more appropriately accounted
for low training set sizes. Likewise, all three aggregation
approaches performed comparably and so SR was con-
sidered here due to the simplicity of implementation.
Hence, on comparing ridge regression to SR across all
simulation scenarios, if one of the models was well cali-
brated (calibration intercepts and slopes significantly
close to zero and one, respectively) and had significantly
higher AUC than the other model, then that modelling
strategy was recommended. Conversely, if both models
were well calibrated but the AUCs were not significantly
different, then a recommendation of “Either” was given.
Finally, if one of the models was miscalibrated then the
other (calibrated) modelling strategy was recommended.
When the size of the training set was less than 500,
then aggregating previously published models by SR was
recommended (Table 2). Conversely, developing a new
model by ridge regression was recommended in situa-
tions where σ > 0.375 and the size of the training set was
at least 1000 observations. Between these scenarios, both
aggregation methods and redevelopment methods pro-
vided indistinguishable performance. Similar recommen-
dations were given when the average event prevalence
was increased to 50% (Table 3).
Discussion
This study demonstrates that aggregating multiple pub-
lished CPMs is a useful derivation strategy, particularly
when there are limited data available. Stacked regression
was a simple yet effective aggregation method, which re-
sulted in predictions and parameter estimates with lowest
MSE given low sample sizes and low between-population-
heterogeneity. These results are consistent with previous
studies [9]. Conversely, AIC derived models were miscali-
brated when the training set sample size was between 150
and 500, confirming that small samples lead to overfitting
in new regression estimates [8, 31, 32]. Ridge regression,
which is a similar concept to parameter shrinkage, miti-
gated overfitting but was potentially susceptible to slight
over-shrinkage. Redevelopment only resulted in a model
with better performance than the aggregation methods
when there was a large amount of training data or the
existing CPMs were significantly heterogeneous.
Fig. 3 Calibration Slope: Calibration slope in the validation set for SR, PCA and the two newly derived models across all simulation situations.
The PLS results were nearly identical to SR/PCA and so are omitted for clarity. Note: σ = 1 was removed from the plot for clarity since the results
quantitatively similar to σ = 0.75
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Previous methodological research around incorporating
existing CPMs has focussed on updating a single existing
model to the new population of interest [7, 8, 10, 33].
These techniques range from model recalibration to the
additional of new risk factors and have been shown to pro-
vide improved performance over deriving new prediction
models, especially when only small datasets are available
[8]. However, updating techniques only adapt one previous
model to the current data. In this sense, the concept of
model aggregation is analogous to meta-analysis since it
aims to synthesise all previous research in the develop-
ment of the CPM. Moreover, CPMs often perform poorly
in high-risk patients. If there are relatively low proportions
of high-risk patients in a given population, then the
Table 2 Modelling strategy recommendations when the mean
incidence of adverse outcome was 20%
σ ntrain
150 250 500 1000 5000 10000
0 SR SR Either Either Either Either
0.125 SR SR Either Either Either Either
0.25 SR SR Either Either Either Either
0.375 SR SR Either Either Ridge Ridge
0.5 SR SR Either Ridge Ridge Ridge
0.75 SR SR Ridge Ridge Ridge Ridge
1.00 SR SR Ridge Ridge Ridge Ridge
Table 3 Modelling strategy recommendations when the mean
incidence of adverse outcome was 50%
σ ntrain
150 250 500 1000 5000 10000
0 SR SR Either Either Either Either
0.125 SR SR Either Either Either Either
0.25 SR SR Either Either Either Either
0.375 SR SR Either Ridge Ridge Ridge
0.5 SR Ridge Ridge Ridge Ridge Ridge
0.75 Ridge Ridge Ridge Ridge Ridge Ridge
1.00 Ridge Ridge Ridge Ridge Ridge Ridge
Fig. 4 Discrimination: Area under receiver operating characteristic curve (AUC) in the validation set for SR, PCA and the two newly derived
models across all scenarios. The PLS results were nearly identical to SR/PCA and so are omitted for clarity. Note: σ = 1 was removed from the plot
for clarity since the results quantitatively similar to σ = 0.75
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development/ update of a CPM to this population can re-
sult in such high-risk, poorly predicted patients becoming
more prevalent since parameter estimates occur for the
population average. In such situations, one should pay
close attention to the residuals of the model; machine-
learning methods such as Boosting are a formal approach
to this.
Since the aim of this study was to examine the benefits
of aggregation over independently deriving a CPM, this
study compared each approach separately to solely ex-
tract the benefit of either method. However, meta-
analysis methods that simultaneously aggregate and re-
develop CPMs have been proposed [18, 34, 35]; utilising
existing CPMs, expert knowledge and new data opti-
mally requires further research. For instance, risk factors
may not be common across existing CPMs, which could
lead to bias if one is interested in simultaneously aggre-
gating and redeveloping CPMs in the local population
[36]. Previous methodology of CPM meta-analysis with
individual patient data has largely been limited to assum-
ing that models share similar risk predictors [10, 18].
Conversely, SR, PCA and PLS relax this assumption
[9]. Indeed, the simulation design of this study allowed
the existing CPMs to be heterogeneous in their risk
predictor set.
Nevertheless, there are potential problems of aggregat-
ing CPMs that require attention. Firstly, each existing
CPM aims to predict the same outcome and most include
very similar subset of predictors, thus inducing a high level
of correlation between the multiple CPMs. Although the
weights in SR are restricted to be non-negative to avoid
situations of negative coefficients caused by inclusion of
two correlated models, further work examining the collin-
earity issues is required [10]. Secondly, differences in risk
factor definitions between existing CPMs could potentially
weaken the performance of SR, PCA or PLS. The current
study aimed to replicate this practical limitation by gener-
ating predictors within clusters of correlated variables;
here, given a moderate degree of correlation between the
multiple similarly defined risk factors, the aggregation
methods still performed well. Finally, datasets across pop-
ulations frequently collect different variables, potentially
meaning a variable included in an existing CPM is not
available in the local population. In such circumstances of
systematically missing covariates, it is unclear how one
should calculate the linear predictor for patients in the
new local population [37]. If systematically missing
risk factors are not handled appropriately, then the
aggregate CPM could be biased.
The main strength of this work is that we perform a
simulation study under a range of realistic scenarios and
consider multiple performance measures, thereby allow-
ing a comprehensive and systematic examination of the
aggregation approaches. Conversely, the main limitation
is that we simulate only a crude reflection of real
between-population-heterogeneity. Over-arching variance
of model parameters does not necessarily reflect the com-
plex differences in data-generating processes that may vary
between populations. However, without a comprehensive
set of joint probability distributions for the covariates of a
given model, accurately modelling population heterogeneity
is difficult to achieve. Hence, confirmation of our findings
will be required from studies in observational datasets. A
further limitation is that publication bias is known to
impact prognostic research [38], but its effects were
not analysed in this study; such bias would lead to over-
estimation of aggregated regression coefficients. Finally,
the aggregation methods assume that each population is a
random sample from an over-arching common popula-
tion. The data-generating mechanisms in this simulation
directly matched this assumption by simulating generating
model coefficients as a random sample from a common
distribution. Similarly, the distributions of the risk predic-
tors were assumed the same between populations.
Overall, the current work suggests a framework of
modelling strategy when developing a model for a
local/ defined population. In practice, an estimate of
the between-population-heterogeneity could be approx-
imated by examining the differences in coefficients be-
tween existing CPMs, exploiting clinical knowledge
between networks of modelling teams and by examin-
ing the distribution of the linear predictors between
populations [39]. In many practical scenarios, the vari-
ability between populations will be low; thus the situa-
tions of σ = 0 to σ = 0.375 in the current study likely
closely represent clinical practice. If the size of the local
data is <10% of that the existing CPMs were derived
on, and if the multiple populations share clinically simi-
lar demographic and procedural characteristics, then
we recommend aggregating existing models. Secondly,
if the size of local data matches or exceeds that of exist-
ing model derivations, then deriving a new CPM could
be appropriate, although the existing CPMs could still
provide useful prior information about likely covariate-
outcome associations. Finally, in all other circumstances,
one should consider either aggregation, redevelopment or
a combination of the two [18]. Here, the sample sizes rela-
tive to the number of predictors per event [31], the esti-
mated population heterogeneity, the quality of the existing
CPMs and the availability of variables should drive the
chosen method.
Conclusions
Aggregating existing CPMs is beneficial in the develop-
ment of a CPM for healthcare predictions in defined
populations. In the majority of situations, modellers
should consider existing CPMs before developing models
anew, with their aggregation potentially providing optimal
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performance given low sample sizes relative to that of pre-
vious model derivations. Deriving a new CPM independ-
ent of previous research was only recommended in the
unusual situation of having more data available than used
to derive existing models, or a local context that is mark-
edly different to those of existing CPMs.
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